TrialDiabetes, obesity & metabolism2019

Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan-L trial.

Francesco Giorgino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.